Julian Yin Borges
About
MD, MS, Associate Professor of Medicine (Endocrinology)
Board Certification in Endocrinology and Metabolism by SBEM/CFM/AMB and
Board Certification in Clinical Nutrition by ABRAN/CFM/AMB.
Dr. Borges is a board-certified endocrinologist and digital health innovator working at the intersection of clinical medicine, artificial intelligence, and precision therapeutics. Currently a scholar in Harvard Medical School’s Global Clinical Scholars Research Training (GCSRT) program and pursuing an MS in Health Informatics at Boston University, he is passionate about transforming molecular insights into scalable, AI-driven interventions that optimize human health.
He is the Founder and Principal Investigator of the MitoCoreX Project, an AI-powered discovery and development platform focused on designing next-generation therapeutics. MitoCoreX identifies novel small molecules and peptides that enhance mitochondrial biogenesis, energy efficiency, and cellular resilience to optimize mitochondrial function. Target indications include aging-related diseases, neurodegenerative conditions, and metabolic optimization. The platform integrates:
Multi-agent AI systems
Genomics-aware targeting
In silico biological simulations
Beyond drug discovery, Dr. Borges’ broader current research integrates:
AI model auditing in genomics-based diagnostics
Hybrid workflows in STATA and Python for causal inference and explainability
Multi-omics integration and biomarker-driven personalization
Evidence synthesis (PRISMA, STROBE), clinical trial design, and bioethics
He serves as Editor-in-Chief of the International Journal of Epidemiology and Public Health Research and as an Academic Editor for PLOS Digital Health. He is also a peer reviewer for leading journals such as the European Heart Journal – Digital Health and the European Journal of Preventive Cardiology.
Dr. Borges is committed to accelerating the development of precision therapeutics through rigorous study design, ethical innovation, and translational impact—bridging healthspan extension with advances in clinical and preventive medicine.
Top-100
Journals
|
1
|
|
|
International Journal of Nutrology
1 publication, 3.13%
|
|
|
American Journal of Biomedical Science & Research
1 publication, 3.13%
|
|
|
Series of Endocrinology Diabetes and Metabolism
1 publication, 3.13%
|
|
|
Cardiology and Cardiovascular Medicine
1 publication, 3.13%
|
|
|
MedNEXT Journal of Medical and Health Sciences
1 publication, 3.13%
|
|
|
Journal of Anesthesia & Pain Medicine
1 publication, 3.13%
|
|
|
International Journal of Preventive Medicine and Care
1 publication, 3.13%
|
|
|
Advancements in Journal of Urology and Nephrology
1 publication, 3.13%
|
|
|
Translational Medicine Open Access
1 publication, 3.13%
|
|
|
Advances in Machine Learning & Artificial Intelligence
1 publication, 3.13%
|
|
|
International Journal of Cardiovascular Medicine
1 publication, 3.13%
|
|
|
1
|
Citing journals
|
1
2
|
|
|
Journal not defined
|
Journal not defined, 2, 28.57%
Journal not defined
2 citations, 28.57%
|
|
International Journal of Molecular Sciences
2 citations, 28.57%
|
|
|
Nutrients
1 citation, 14.29%
|
|
|
Antioxidants
1 citation, 14.29%
|
|
|
Bulletin of Reproductive Health
1 citation, 14.29%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
|
|
|
Opast Group LLC
5 publications, 15.63%
|
|
|
Zotarelli-Filho Scientific Works
2 publications, 6.25%
|
|
|
Fortune Journals
1 publication, 3.13%
|
|
|
Auctores Publishing LLC
1 publication, 3.13%
|
|
|
BiomedGrid LLC
1 publication, 3.13%
|
|
|
SeriesScience International
1 publication, 3.13%
|
|
|
1
2
3
4
5
|
Organizations from articles
|
5
10
15
20
25
30
35
|
|
|
Organization not defined
|
Organization not defined, 32, 100%
Organization not defined
32 publications, 100%
|
|
5
10
15
20
25
30
35
|
Countries from articles
|
5
10
15
20
25
30
35
|
|
|
Country not defined
|
Country not defined, 32, 100%
Country not defined
32 publications, 100%
|
|
5
10
15
20
25
30
35
|
Citing organizations
|
1
2
|
|
|
Organization not defined
|
Organization not defined, 2, 28.57%
Organization not defined
2 citations, 28.57%
|
|
Russian University of Medicine
1 citation, 14.29%
|
|
|
Endocrinology Research Centre
1 citation, 14.29%
|
|
|
Shahid Beheshti University of Medical Sciences and Health Services
1 citation, 14.29%
|
|
|
Shiraz University of Medical Sciences
1 citation, 14.29%
|
|
|
Isfahan University of Medical Sciences
1 citation, 14.29%
|
|
|
Kermanshah University of Medical Sciences
1 citation, 14.29%
|
|
|
University of Isfahan
1 citation, 14.29%
|
|
|
Sulaimani Polytechnic University
1 citation, 14.29%
|
|
|
Maragheh University of Medical Sciences
1 citation, 14.29%
|
|
|
University of Halabja
1 citation, 14.29%
|
|
|
University of Melbourne
1 citation, 14.29%
|
|
|
Monash University
1 citation, 14.29%
|
|
|
La Trobe University
1 citation, 14.29%
|
|
|
Swinburne University of Technology
1 citation, 14.29%
|
|
|
Baker IDI Heart and Diabetes Institute
1 citation, 14.29%
|
|
|
Dalhousie University
1 citation, 14.29%
|
|
|
Université Clermont Auvergne
1 citation, 14.29%
|
|
|
Carol Davila University of Medicine and Pharmacy
1 citation, 14.29%
|
|
|
Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca
1 citation, 14.29%
|
|
|
Stefan Cel Mare University
1 citation, 14.29%
|
|
|
1
2
|
Citing countries
|
1
2
3
|
|
|
Country not defined
|
Country not defined, 3, 42.86%
Country not defined
3 citations, 42.86%
|
|
Romania
|
Romania, 2, 28.57%
Romania
2 citations, 28.57%
|
|
Russia
|
Russia, 1, 14.29%
Russia
1 citation, 14.29%
|
|
France
|
France, 1, 14.29%
France
1 citation, 14.29%
|
|
Australia
|
Australia, 1, 14.29%
Australia
1 citation, 14.29%
|
|
Iraq
|
Iraq, 1, 14.29%
Iraq
1 citation, 14.29%
|
|
Iran
|
Iran, 1, 14.29%
Iran
1 citation, 14.29%
|
|
Canada
|
Canada, 1, 14.29%
Canada
1 citation, 14.29%
|
|
1
2
3
|
- We do not take into account publications without a DOI.
- Statistics recalculated daily.
